Revenue, last quarter
$51K
+82.1% vs same quarter last year
Net income
−$475K
+81.3% vs same quarter last year
EPS, diluted
−$0.03
+96.9% vs same quarter last year
Operating cash flow
−$2.5M
−4.2% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY26 | $131K | −$13.8M |
| FY25 | $144K | −$2.5M |
| FY24 | $109K | −$14.7M |
| FY23 | $370K | −$17.3M |
| FY22 | $1.5M | −$11.4M |
| FY21 | $0 | −$16.8M |
| FY20 | $2.2M | −$18.7M |
| FY19 | $3.1M | −$26.6M |
| FY18 | $4.6M | −$34.8M |
| FY17 | $4.2M | −$38.4M |
| FY16 | $1.5M | −$38.6M |
| FY15 | $571K | −$30.1M |
| FY14 | $379K | −$25.8M |
| FY13 | $1.2M | −$43.6M |
| FY12 | $969K | −$4.4M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY26 | 100% | −8768.7% | −10567.2% |
| FY25 | 96.5% | −8761.1% | −1727.8% |
| FY24 | - | −13840.4% | −13459.6% |
| FY23 | - | −4792.2% | −4664.6% |
| FY22 | - | −765.3% | −763.2% |
| FY21 | - | - | - |
| FY20 | 86.3% | −977.9% | −852% |
| FY19 | 83.8% | −882.4% | −861.7% |
| FY18 | 78.3% | −766.3% | −756.1% |
| FY17 | 77.4% | −911.9% | −908.9% |
| FY16 | 100% | −2605.7% | −2601.1% |
| FY15 | 100% | −5306% | −5268.3% |
| FY14 | - | −5448.3% | −6820.1% |
| FY13 | - | −778.5% | −3638.5% |
| FY12 | 87.5% | −237.9% | −452.3% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY26 | −$10.8M |
| FY25 | −$9.5M |
| FY24 | −$14.7M |
| FY23 | −$12.8M |
| FY22 | −$8.9M |
| FY21 | −$13.7M |
| FY20 | −$14.9M |
| FY19 | −$20.5M |
| FY18 | −$29.1M |
| FY17 | −$30.5M |
| FY16 | −$31.5M |
| FY15 | −$21.1M |
| FY14 | −$15.8M |
| FY13 | −$10.1M |
| FY12 | −$2M |
Show the numbers
| Year | Buybacks |
|---|---|
| FY26 | - |
| FY25 | - |
| FY24 | - |
| FY23 | - |
| FY22 | $0 |
| FY21 | $1K |
| FY20 | $0 |
| FY19 | - |
| FY18 | - |
| FY17 | - |
| FY16 | - |
| FY15 | - |
| FY14 | - |
| FY13 | - |
| FY12 | - |
- VivoSim Labs
- Healthcare median
Show the numbers
| Year | VivoSim Labs | Healthcare median |
|---|---|---|
| FY26 | −10567.2% | −11.1% |
| FY25 | −1727.8% | −30.6% |
| FY24 | −13459.6% | −47% |
| FY23 | −4664.6% | −58% |
| FY22 | −763.2% | −80.4% |
| FY21 | - | −71.8% |
| FY20 | −852% | −62.2% |
| FY19 | −861.7% | −46.2% |
| FY18 | −756.1% | −49.6% |
| FY17 | −908.9% | −45.9% |
| FY16 | −2601.1% | −36% |
| FY15 | −5268.3% | −37.8% |
| FY14 | −6820.1% | −35.5% |
| FY13 | −3638.5% | −37.1% |
| FY12 | −452.3% | −29.1% |